Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Applying to Mid Florida Hematology and Oncology Center · Orange City, Florida
Answer a few short questions to share with the research team.